Profil
Mr. Kevin T.
Ferro is a Chief Executive Officer at Ferro Holdings LLC (New York), a Founder, Chief Executive Officer at Vatera Healthcare Partners, a Chairman at Arisaph Pharmaceuticals, Inc. and a Chairman at ImmusanT, Inc. He is on the Board of Directors at Ekteino Laboratories, Inc.
Mr. Ferro was previously employed as an Independent Director by Greenhill & Co., Inc., a Chairman by Melinta Therapeutics, Inc., a Chairman by Pearl Therapeutics, Inc., a Chief Executive & Investment Officer by Oikos Holdings LLC, a Chief Executive Officer & Investment Officer by Ferro Capital LLC, a Global Head-Alternative Investment Strategies by Commerzbank AG, and a Vice President by D.
E.
Shaw & Co. LP.
He also served on the board at KOS Pharmaceuticals, Inc., Eltrak SA and Melinta Subsidiary Corp.
He received his undergraduate degree from Harvard University.
Postes actifs de Kevin Thomas Ferro
| Sociétés | Poste | Début |
|---|---|---|
Arisaph Pharmaceuticals, Inc.
Arisaph Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery services | Président | 01/01/2005 |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company which develops a treatment, and a set of diagnostic and monitoring tools to manage patients with celiac disease | Président | - |
Ekteino Laboratories, Inc.
Ekteino Laboratories, Inc. BiotechnologyHealth Technology Develops sustained-release drug delivery system for chronic use medications | Directeur/Membre du Conseil | - |
Ferro Holdings LLC (New York)
Ferro Holdings LLC (New York) Financial ConglomeratesFinance Functions as an investment holding company | Directeur Général | 01/08/2019 |
Anciens postes connus de Kevin Thomas Ferro
| Sociétés | Poste | Fin |
|---|---|---|
| GREENHILL & CO., INC. | Directeur/Membre du Conseil | 30/11/2023 |
| MELINTA THERAPEUTICS, INC. | Président | 05/08/2019 |
Oikos Holdings LLC
Oikos Holdings LLC Investment ManagersFinance Operates as a holding company that provides financial advisory services | Directeur Général | 31/12/2018 |
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases | Président | 01/06/2013 |
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | - |
Formation de Kevin Thomas Ferro
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
D. E. Shaw & Co. LP
D. E. Shaw & Co. LP Investment ManagersFinance DESCO employs a combination of quantitative and qualitative tools to uncover independent, hard-to-find sources of return across global public and private markets. Their investment activities may be divided into three broad categories—systematic strategies based on quantitative and computational techniques, discretionary strategies based primarily on human analysis, and hybrid strategies that combine systematic and discretionary approaches to investing. | Finance |
Arisaph Pharmaceuticals, Inc.
Arisaph Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery services | Health Technology |
Commerzbank AG
Commerzbank AG Regional BanksFinance Provides commercial banking services | Finance |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eltrak SA
Eltrak SA Wholesale DistributorsDistribution Services Sells earthmoving and lifting machinery, generators, forklifts and marine engines | Distribution Services |
Greenhill & Co., Inc.
Greenhill & Co., Inc. Investment Banks/BrokersFinance Operates as an investment bank that provides financial advisory services | Finance |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Oikos Holdings LLC
Oikos Holdings LLC Investment ManagersFinance Operates as a holding company that provides financial advisory services | Finance |
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases | Health Technology |
Ferro Capital LLC
Ferro Capital LLC Investment ManagersFinance Provides investment advice | Finance |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company which develops a treatment, and a set of diagnostic and monitoring tools to manage patients with celiac disease | Health Technology |
Ekteino Laboratories, Inc.
Ekteino Laboratories, Inc. BiotechnologyHealth Technology Develops sustained-release drug delivery system for chronic use medications | Health Technology |
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
Ferro Holdings LLC (New York)
Ferro Holdings LLC (New York) Financial ConglomeratesFinance Functions as an investment holding company | Finance |
















